Procedure for Stability Testing for IND Applications
1) Purpose
The purpose of this SOP is to define the procedures for conducting stability studies required for Investigational New Drug (IND) applications. This SOP ensures that stability data is generated in compliance with regulatory guidelines to support the safety and efficacy of the drug product during clinical trials.
2) Scope
This SOP applies to all personnel involved in the preparation, execution, and documentation of stability testing for drug products intended for IND applications to the US FDA.
3) Responsibilities
Clinical Research Team: Responsible for coordinating with stability testing teams to provide necessary study requirements.
Stability Study Team: Responsible for conducting stability testing as per IND guidelines.
Regulatory Affairs Team: Responsible for ensuring compliance with US FDA IND regulations.
4) Procedure
4.1 Development of Stability Protocol
4.1.1 Develop a stability protocol in accordance with US FDA IND guidelines.
4.1.2 Include
4.2 Sample Collection and Storage
4.2.1 Collect samples from each batch of the investigational drug product.
4.2.2 Store samples under conditions representative of those anticipated during the clinical study.
4.3 Testing and Monitoring
4.3.1 Conduct stability tests at specified intervals, including physical, chemical, microbiological, and other relevant tests.
4.3.2
4.4 Data Analysis and Reporting
4.4.1 Analyze collected data to assess the stability of the investigational drug product.
4.4.2 Prepare stability data reports to be included in the IND application submission to the US FDA.
5) Abbreviations, if any
IND: Investigational New Drug
FDA: US Food and Drug Administration
6) Documents, if any
6.1 Stability testing protocols
6.2 IND application documents
6.3 Stability testing records
7) Reference, if any
US FDA Guidance for Industry: IND Applications, Stability Testing Guidelines
8) SOP Version
Version 1.0